2023 Q3 Form 10-Q Financial Statement
#000095017023042476 Filed on August 14, 2023
Income Statement
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
Revenue | $0.00 | $2.000K | $863.0K |
YoY Change | -100.0% | -99.77% | -95.39% |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $12.77M | $8.953M | $8.410M |
YoY Change | 56.79% | 6.46% | -62.98% |
% of Gross Profit | |||
Research & Development | $10.55M | $5.983M | $5.904M |
YoY Change | 81.22% | 1.34% | -55.94% |
% of Gross Profit | |||
Depreciation & Amortization | $100.0K | $200.0K | $200.0K |
YoY Change | -50.0% | 0.0% | -60.0% |
% of Gross Profit | |||
Operating Expenses | $23.32M | $14.94M | $14.31M |
YoY Change | 66.97% | 4.35% | -60.37% |
Operating Profit | -$23.32M | -$14.93M | -$14.21M |
YoY Change | 67.93% | 5.1% | -60.14% |
Interest Expense | $2.592M | $2.703M | $2.772M |
YoY Change | -6.53% | -2.49% | -20.85% |
% of Operating Profit | |||
Other Income/Expense, Net | -$52.11M | -$5.000K | $5.735M |
YoY Change | 52008.0% | -100.09% | 97.69% |
Pretax Income | -$73.45M | -$17.80M | -$6.834M |
YoY Change | 399.14% | 160.51% | -83.49% |
Income Tax | $1.000K | $4.000K | -$837.0K |
% Of Pretax Income | |||
Net Earnings | -$73.45M | -$17.81M | -$5.513M |
YoY Change | 1336.33% | 223.0% | -92.98% |
Net Earnings / Revenue | -890350.0% | -638.82% | |
Basic Earnings Per Share | -$4.89 | -$1.47 | -$0.75 |
Diluted Earnings Per Share | -$4.89 | -$1.47 | -$29.90K |
COMMON SHARES | |||
Basic Shares Outstanding | 13.88M | 11.86M | 184.2M |
Diluted Shares Outstanding | 15.02M | 12.14M | 7.375M |
Balance Sheet
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $12.60M | $26.45M | $48.51M |
YoY Change | -66.0% | -45.47% | -26.5% |
Cash & Equivalents | $7.800M | $22.70M | $48.50M |
Short-Term Investments | |||
Other Short-Term Assets | $172.0K | $193.0K | $1.060M |
YoY Change | -78.45% | -81.79% | 96.66% |
Inventory | |||
Prepaid Expenses | $3.179M | $3.912M | $7.615M |
Receivables | $0.00 | ||
Other Receivables | $817.0K | ||
Total Short-Term Assets | $19.25M | $33.89M | $60.15M |
YoY Change | -58.48% | -43.66% | -47.39% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $1.236M | $1.351M | $2.454M |
YoY Change | -41.48% | -44.95% | -55.17% |
Goodwill | $6.072M | $6.072M | $6.072M |
YoY Change | 0.0% | 0.0% | |
Intangibles | |||
YoY Change | |||
Long-Term Investments | $6.000M | $6.000M | $6.000M |
YoY Change | 0.0% | 0.0% | |
Other Assets | $6.314M | $6.478M | $6.227M |
YoY Change | 1.4% | 4.03% | 4165.07% |
Total Long-Term Assets | $15.46M | $15.79M | $16.96M |
YoY Change | -4.91% | -6.89% | 201.71% |
TOTAL ASSETS | |||
Total Short-Term Assets | $19.25M | $33.89M | $60.15M |
Total Long-Term Assets | $15.46M | $15.79M | $16.96M |
Total Assets | $34.70M | $49.67M | $77.10M |
YoY Change | -44.58% | -35.57% | -35.72% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.905M | $5.042M | $4.315M |
YoY Change | 65.75% | 16.85% | -70.36% |
Accrued Expenses | $21.10M | $21.27M | $28.80M |
YoY Change | 7.97% | -26.15% | -50.11% |
Deferred Revenue | $42.00K | $42.00K | $89.00K |
YoY Change | -28.81% | -52.81% | -79.91% |
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | ||
YoY Change | -100.0% | ||
Total Short-Term Liabilities | $69.54M | $37.67M | $40.58M |
YoY Change | 153.89% | -7.19% | -52.61% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $80.40M | $128.6M | $127.1M |
YoY Change | -36.91% | 1.17% | -19.96% |
Other Long-Term Liabilities | $3.567M | $4.318M | $5.537M |
YoY Change | -31.68% | -22.02% | -62.48% |
Total Long-Term Liabilities | $3.567M | $4.318M | $5.537M |
YoY Change | -31.68% | -22.02% | -62.48% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $69.54M | $37.67M | $40.58M |
Total Long-Term Liabilities | $3.567M | $4.318M | $5.537M |
Total Liabilities | $153.5M | $170.6M | $173.2M |
YoY Change | -4.1% | -1.53% | -33.27% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$935.5M | -$862.1M | -$808.0M |
YoY Change | 15.05% | 6.7% | 23.91% |
Common Stock | $835.8M | $760.3M | $731.0M |
YoY Change | 13.76% | 4.01% | 37.6% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$118.8M | -$120.9M | -$96.11M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $34.70M | $49.67M | $77.10M |
YoY Change | -44.58% | -35.57% | -35.72% |
Cashflow Statement
Concept | 2023 Q3 | 2023 Q2 | 2022 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$73.45M | -$17.81M | -$5.513M |
YoY Change | 1336.33% | 223.0% | -92.98% |
Depreciation, Depletion And Amortization | $100.0K | $200.0K | $200.0K |
YoY Change | -50.0% | 0.0% | -60.0% |
Cash From Operating Activities | -$11.03M | -$11.62M | -$19.64M |
YoY Change | 12.49% | -40.82% | -44.97% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $20.00K | -$214.0K |
YoY Change | -100.0% | -109.35% | -45.13% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $1.000K | $0.00 |
YoY Change | -100.0% | ||
Cash From Investing Activities | $0.00 | -$19.00K | -$214.0K |
YoY Change | -100.0% | -91.12% | -61.65% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -2.850M | 7.630M | 1.125M |
YoY Change | 92.96% | 578.22% | -97.0% |
NET CHANGE | |||
Cash From Operating Activities | -11.03M | -11.62M | -19.64M |
Cash From Investing Activities | 0.000 | -19.00K | -214.0K |
Cash From Financing Activities | -2.850M | 7.630M | 1.125M |
Net Change In Cash | -13.88M | -4.011M | -18.73M |
YoY Change | 21.27% | -78.58% | -1573.49% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$11.03M | -$11.62M | -$19.64M |
Capital Expenditures | $0.00 | $20.00K | -$214.0K |
Free Cash Flow | -$11.03M | -$11.64M | -$19.43M |
YoY Change | 14.41% | -40.07% | -44.97% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-3.01 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001580063 | ||
CY2023Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023Q2 | us-gaap |
Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
|
http://bioratherapeutics.com/20230630#AccruedExpensesAndOtherLiabilitiesCurrent | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-39334 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Biora Therapeutics, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
27-3950390 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
4330 La Jolla Village Drive | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 300 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
San Diego | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92122 | ||
dei |
City Area Code
CityAreaCode
|
833 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
727-2841 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.001 per share | ||
dei |
Trading Symbol
TradingSymbol
|
BIOR | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
13883762 | |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
26452000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
30486000 | |
CY2023Q2 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
819000 | |
CY2022Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
828000 | |
CY2023Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4105000 | |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4199000 | |
CY2023Q2 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
2509000 | |
CY2022Q4 | us-gaap |
Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
2603000 | |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
33885000 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
38116000 | |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1351000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1654000 | |
CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1887000 | |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1482000 | |
CY2023Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
6478000 | |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
6201000 | |
CY2023Q2 | us-gaap |
Goodwill
Goodwill
|
6072000 | |
CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
6072000 | |
CY2023Q2 | us-gaap |
Assets
Assets
|
49673000 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
53525000 | |
CY2023Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5042000 | |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3606000 | |
CY2023Q2 | bior |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
21791000 | |
CY2022Q4 | bior |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
16161000 | |
CY2023Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
10835000 | |
CY2022Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
3538000 | |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
37668000 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
23305000 | |
CY2023Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
128568000 | |
CY2022Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
127811000 | |
CY2023Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
4318000 | |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
4696000 | |
CY2023Q2 | us-gaap |
Liabilities
Liabilities
|
170554000 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
155812000 | |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
164000000 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
164000000 | |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
13686964 | |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
9098844 | |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
13420859 | |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
8928498 | |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
11000 | |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
8000 | |
CY2023Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
760277000 | |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
743626000 | |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-862091000 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-826843000 | |
CY2023Q2 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
266105 | |
CY2022Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
170346 | |
CY2023Q2 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
19078000 | |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.81 | |
us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-3.01 | ||
CY2022Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
19078000 | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-120881000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-102287000 | |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
49673000 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
53525000 | |
CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2000 | |
CY2022Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
104000 | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4000 | ||
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
211000 | ||
CY2023Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5983000 | |
CY2022Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5904000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
13173000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
12462000 | ||
CY2023Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
8953000 | |
CY2022Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
8410000 | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
17309000 | ||
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
21867000 | ||
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
14936000 | |
CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
14314000 | |
us-gaap |
Operating Expenses
OperatingExpenses
|
30482000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
34329000 | ||
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14934000 | |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-14210000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-30478000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-34118000 | ||
CY2023Q2 | us-gaap |
Interest Expense
InterestExpense
|
2703000 | |
CY2022Q2 | us-gaap |
Interest Expense
InterestExpense
|
2772000 | |
us-gaap |
Interest Expense
InterestExpense
|
5383000 | ||
us-gaap |
Interest Expense
InterestExpense
|
5532000 | ||
CY2023Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
161000 | |
CY2022Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-4413000 | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-703000 | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-13402000 | ||
CY2023Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-5000 | |
CY2022Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
5735000 | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-86000 | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
4924000 | ||
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-17803000 | |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-6834000 | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-35244000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-21324000 | ||
CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4000 | |
CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-837000 | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-837000 | ||
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-17807000 | |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-5997000 | |
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-35248000 | ||
us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
-20487000 | ||
CY2023Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | |
CY2022Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
484000 | |
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
0 | ||
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
1166000 | ||
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17807000 | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5513000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-35248000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-19321000 | ||
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-1.47 | |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-1.47 | |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.81 | |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-96106000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-35248000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-19321000 | ||
us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
0 | ||
us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
1166000 | ||
bior |
Non Cash Revenue Reserve
NonCashRevenueReserve
|
0 | ||
bior |
Non Cash Revenue Reserve
NonCashRevenueReserve
|
201000 | ||
us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-2.79 | ||
us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-2.79 | ||
CY2023Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0 | |
CY2023Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0 | |
CY2022Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.06 | |
CY2022Q2 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.06 | |
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0 | ||
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0 | ||
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.16 | ||
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.16 | ||
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.47 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.47 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.75 | |
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.75 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-3.01 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-3.01 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.63 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.63 | ||
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12143108 | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12143108 | |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7374865 | |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7374865 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
11718408 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
11718408 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7351595 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7351595 | ||
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-102287000 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
12524000 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
-178000 | |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2384000 | |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17441000 | |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-104998000 | |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
-90000 | |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2014000 | |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-17807000 | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-120881000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-84976000 | |
CY2022Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3626000 | |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
-80000 | |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2053000 | |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13808000 | |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-93185000 | |
CY2022Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1168000 | |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
89000 | |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
-111000 | |
CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1446000 | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5513000 | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
313000 | ||
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
547000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4398000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3499000 | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
757000 | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
694000 | ||
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-9000 | ||
us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-320000 | ||
us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
100000 | ||
us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
-545000 | ||
us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
0 | ||
us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
5731000 | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-703000 | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-13402000 | ||
us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
-10000 | ||
us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
817000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
59000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
904000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1437000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-4434000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
6170000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
-4486000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-904000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
-958000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-23720000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-45413000 | ||
us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
0 | ||
us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
1819000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-23720000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-43594000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
36000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
556000 | ||
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
11000 | ||
us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
0 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-25000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-556000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
12883000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4794000 | ||
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
8000000 | ||
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | ||
us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
0 | ||
us-gaap |
Proceeds From Stock Plans
ProceedsFromStockPlans
|
89000 | ||
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
484000 | ||
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
0 | ||
bior |
Payments For Insurance Financing
PaymentsForInsuranceFinancing
|
688000 | ||
bior |
Payments For Insurance Financing
PaymentsForInsuranceFinancing
|
612000 | ||
bior |
Principal Payments On Capital Lease Obligations
PrincipalPaymentsOnCapitalLeaseObligations
|
0 | ||
bior |
Principal Payments On Capital Lease Obligations
PrincipalPaymentsOnCapitalLeaseObligations
|
12000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
19711000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
4259000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-4034000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-39891000 | ||
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
30486000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
88397000 | |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
26452000 | |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
48506000 | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
1059000 | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
4811000 | ||
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
11000 | ||
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
17000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
1133000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
2922000 | ||
bior |
Enumera Molecular Investment In Exchange For Assets
EnumeraMolecularInvestmentInExchangeForAssets
|
0 | ||
bior |
Enumera Molecular Investment In Exchange For Assets
EnumeraMolecularInvestmentInExchangeForAssets
|
6000000 | ||
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
0 | ||
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
40000 | ||
CY2023Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
22700000 | |
CY2023Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
3800000 | |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-862100000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-35200000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-23700000 | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates include the valuation of stock options, the valuation of goodwill, accrual for reimbursement claims and settlements, the valuation of warrant liabilities, the valuation of assets held for sale, assessing future tax exposure and the realization of deferred tax assets, and the useful lives and the recoverability of property and equipment. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</span></p> | ||
CY2023Q2 | us-gaap |
Restricted Cash And Investments
RestrictedCashAndInvestments
|
3800000 | |
CY2022Q4 | us-gaap |
Restricted Cash And Investments
RestrictedCashAndInvestments
|
0 | |
CY2023Q2 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
0 | |
us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
0 | ||
CY2022Q2 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
759000 | |
us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
2027000 | ||
CY2022Q2 | bior |
Disposal Group Including Discontinued Operation Selling General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense
|
275000 | |
bior |
Disposal Group Including Discontinued Operation Selling General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationSellingGeneralAndAdministrativeExpense
|
861000 | ||
CY2022Q2 | us-gaap |
Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
|
275000 | |
us-gaap |
Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
|
861000 | ||
CY2022Q2 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
484000 | |
us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
1166000 | ||
CY2022Q2 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
500000 | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
1900000 | ||
CY2022Q4 | bior |
Accrued Interest Current
AccruedInterestCurrent
|
890000 | |
CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
810000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
893000 | |
CY2023Q2 | us-gaap |
Accrued Insurance Current
AccruedInsuranceCurrent
|
1517000 | |
CY2023Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
3912000 | |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
3634000 | |
CY2023Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
193000 | |
CY2022Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
565000 | |
CY2023Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4105000 | |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4199000 | |
CY2023Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3750000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5653000 | |
CY2023Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2399000 | |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3999000 | |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1351000 | |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1654000 | |
CY2023Q2 | us-gaap |
Depreciation
Depreciation
|
200000 | |
us-gaap |
Depreciation
Depreciation
|
300000 | ||
CY2022Q2 | us-gaap |
Depreciation
Depreciation
|
200000 | |
us-gaap |
Depreciation
Depreciation
|
500000 | ||
CY2023Q2 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
478000 | |
CY2022Q4 | us-gaap |
Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
|
201000 | |
CY2023Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
6478000 | |
CY2022Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
6201000 | |
CY2023Q2 | bior |
Accrual For Reimbursement Claims And Settlements Current
AccrualForReimbursementClaimsAndSettlementsCurrent
|
8472000 | |
CY2022Q4 | bior |
Accrual For Reimbursement Claims And Settlements Current
AccrualForReimbursementClaimsAndSettlementsCurrent
|
8372000 | |
CY2023Q2 | bior |
Commission And Bonus Current
CommissionAndBonusCurrent
|
1351000 | |
CY2022Q4 | bior |
Commission And Bonus Current
CommissionAndBonusCurrent
|
1433000 | |
CY2023Q2 | bior |
Vacation And Payroll Benefits Current
VacationAndPayrollBenefitsCurrent
|
1353000 | |
CY2022Q4 | bior |
Vacation And Payroll Benefits Current
VacationAndPayrollBenefitsCurrent
|
1724000 | |
CY2023Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
817000 | |
CY2022Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
307000 | |
CY2023Q2 | bior |
Accrued Interest Current
AccruedInterestCurrent
|
4687000 | |
CY2022Q4 | us-gaap |
Accrued Insurance Current
AccruedInsuranceCurrent
|
445000 | |
CY2023Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
42000 | |
CY2022Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
47000 | |
CY2023Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2742000 | |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2050000 | |
CY2023Q2 | bior |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
21791000 | |
CY2022Q4 | bior |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
16161000 | |
CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1127000 | |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
601000 | |
CY2023Q2 | us-gaap |
Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
|
3191000 | |
CY2022Q4 | us-gaap |
Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
|
4095000 | |
CY2023Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
4318000 | |
CY2022Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
4696000 | |
CY2023Q2 | bior |
Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
|
0 | |
CY2022Q2 | bior |
Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
|
0 | |
CY2023Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
128600000 | |
CY2022Q4 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
127800000 | |
CY2023Q2 | us-gaap |
Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
|
73100000 | |
CY2022Q4 | us-gaap |
Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
|
71800000 | |
CY2023Q2 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
4200000 | |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
4900000 | |
CY2023Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
5.30 | |
CY2023Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
3018868 | |
CY2023Q2 | bior |
Common Stock Ownership Percentage
CommonStockOwnershipPercentage
|
0.05 | |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
800000 | ||
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
400000 | ||
CY2023Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
400 | |
CY2022Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
400 | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
800 | ||
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
700 | ||
CY2023Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y6M | |
CY2022Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y2M12D | |
CY2023Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.096 | |
CY2022Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.078 | |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
|
497000 | |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
938000 | |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
507000 | |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
215000 | |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
18000 | |
CY2023Q2 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
2175000 | |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
238000 | |
CY2023Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1937000 | |
CY2020Q3 | bior |
Number Of States Participating In Settlement
NumberOfStatesParticipatingInSettlement
|
45 | |
CY2020Q4 | bior |
Aggregate Amount Of Historical Payments
AggregateAmountOfHistoricalPayments
|
27400000 | |
CY2023Q2 | bior |
Payor Recoupment
PayorRecoupment
|
1100000 | |
CY2020Q4 | bior |
Number Of Actions Pending
NumberOfActionsPending
|
2 | |
CY2020Q4 | bior |
Number Of Actions Pending
NumberOfActionsPending
|
2 | |
CY2023Q1 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
On January 3, 2023, the Company effected a 1-for-25 reverse stock split of the Company's common stock. | |
CY2021Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
77280 | |
bior |
Gain Loss On Warrant Liability
GainLossOnWarrantLiability
|
13400000 | ||
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
1300250 | |
CY2022Q4 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
9000000.0 | |
CY2022Q4 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
6000000.0 | |
CY2022Q4 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
1600000 | |
CY2022Q4 | bior |
Warrants And Common Stock Issuance Cost
WarrantsAndCommonStockIssuanceCost
|
800000 | |
CY2022Q4 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
900000 | |
CY2023Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
5.30 | |
CY2023Q2 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
3018868 | |
CY2023Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
5.05 | |
CY2023Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
7300000 | |
us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
8000000.0 | ||
bior |
Gain Loss On Warrant Liability
GainLossOnWarrantLiability
|
1000000.0 | ||
bior |
Warrants And Common Stock Issuance Cost
WarrantsAndCommonStockIssuanceCost
|
700000 | ||
CY2023Q2 | bior |
Remeasurement Of Warrant Liability
RemeasurementOfWarrantLiability
|
6900000 | |
CY2023Q2 | bior |
Gain Loss On Warrant Liability
GainLossOnWarrantLiability
|
2100000 | |
CY2022Q4 | bior |
Number Of Vote Per Preferred Stock Held
NumberOfVotePerPreferredStockHeld
|
3000 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
582557 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
59.89 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
187400 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.97 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
20297 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
42.33 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
40928 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
110.06 | ||
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
708732 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
42.71 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y4M24D | ||
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
49000 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
708732 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
42.71 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y4M24D | ||
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
49000 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
230465 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
78.31 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P7Y3M18D | ||
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
0 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.035 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.040 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.020 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.036 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.013 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.027 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.907 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.013 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.93 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
19.53 | ||
CY2023Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2014000 | |
CY2022Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1446000 | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4398000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3499000 | ||
CY2023Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
8500000 | |
us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y9M18D | ||
CY2023Q2 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0 | |
CY2022Q2 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0 | |
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0 | ||
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
8804945 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3574315 |